LMNB2 and prostate adenocarcinoma: The forest plots revealed that an up-regulated LMNB2 expression level was associated with poor OS in ACC, kidney renal papillary cell carcinoma (KIRP), brain lower grade glioma (LGG), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), MESO, prostate adenocarcinoma (PRAD), SARC and skin cutaneous melanoma (SKCM).